The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First prospective observational study in diffuse-type tenosynovial giant cell tumors.
 
Monique Mastboom
Research Funding - Daiichi Sankyo
 
Emanuela Palmerini
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Lilly
Research Funding - Daiichi Sankyo; PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Takeda
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Eric Staals
Travel, Accommodations, Expenses - Daiichi Sankyo; Schlesinger Associates
 
Bart Schreuder
No Relationships to Disclose
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Lilly; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar
 
John H. Healey
Consulting or Advisory Role - Daiichi Sankyo; Stryker
Research Funding - Illuminoss
 
Julio López Bastida
Honoraria - Biogen; Lilly
Consulting or Advisory Role - Biogen; Lilly
Research Funding - Biogen; Lilly
 
Hans Gelderblom
Patents, Royalties, Other Intellectual Property - Amgen, Boehringer-Ingelheim, Pfizer, Novartis, Pharmamar, Daiichi, Five Prime (Inst)
Other Relationship - Daiichi Sankyo
 
Andreas Leithner
Speakers' Bureau - PharmaMar
Research Funding - AlphaMed
 
Michiel van de Sande
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Daiichi Sankyo; Daiichi Sankyo (Inst)